Terns Pharmaceuticals (TERN) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.32
-0.29
-0.27
-0.24

Details

Expected EPS
-0.290336
Actual EPS
-0.26
Surprise EPS
0.03
Surprise Percent
+10.45%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.26 per share for Q3 2025.

0 Comments

Share your thoughts